Cytisine for vaping
A proposed independent study of cytisine, a plant-based compound already used in some countries to help smokers quit, in people who only vape.
Exhale is a new, open research network for better ways to quit nicotine vapes. The plan: people who vape, clinicians and researchers decide together which studies get funded, every result is published openly, and contributors earn EXHALE.
Contract not deployed yet. The official address is published here at launch.
Your usual strength, logged every day.
The first step down, with cravings tracked.
Half again. A slip is data, not failure.
The last step before zero.
Nicotine-free. The registry keeps counting.
A proposed schedule for the Nicotine step-down pods study, which has not started. It is not medical advice.
US middle and high school students currently use e-cigarettes.
Source: CDC National Youth Tobacco Survey, 2024of those students vape every day.
Source: CDC National Youth Tobacco Survey, 2024of US adults currently use e-cigarettes, up from 4.5% in 2019.
Source: CDC National Health Interview Survey, 2023Most quit programs and medicines were designed for smokers, not for the constant, all-day nicotine of a vape. Exhale pools community funding into research made for people who vape, keeps the data open, and lets the people trying to quit decide what gets studied next.
A proposed independent study of cytisine, a plant-based compound already used in some countries to help smokers quit, in people who only vape.
A proposed structured taper that lowers nicotine strength week by week, measuring cravings and relapse along the way.
A proposed test of whether heart rate and sleep data can warn someone of a craving early enough to act on it.
A planned registry of anonymised member quit attempts, methods and outcomes, to be published for any lab to analyse.
Exhale is pre-launch. Follow along, and help decide which study comes first.